申请人:AGIOS PHARMACEUTICALS, INC
公开号:US20170183311A1
公开(公告)日:2017-06-29
Compounds and compositions comprising compounds that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of cancer.